nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—cerebellar cortex—hypothyroidism	0.13	0.185	CbGeAlD
Ingenol Mebutate—PRKCA—brown adipose tissue—hypothyroidism	0.109	0.155	CbGeAlD
Ingenol Mebutate—PRKCA—nerve—hypothyroidism	0.0477	0.0677	CbGeAlD
Ingenol Mebutate—PRKCD—adrenal cortex—hypothyroidism	0.0332	0.0472	CbGeAlD
Ingenol Mebutate—PRKCD—heart—hypothyroidism	0.0321	0.0456	CbGeAlD
Ingenol Mebutate—PRKCA—WNT5A-dependent internalization of FZD4—CLTC—hypothyroidism	0.0288	0.0973	CbGpPWpGaD
Ingenol Mebutate—PRKCD—gonad—hypothyroidism	0.0275	0.0391	CbGeAlD
Ingenol Mebutate—PRKCD—pituitary gland—hypothyroidism	0.0268	0.0381	CbGeAlD
Ingenol Mebutate—PRKCD—adrenal gland—hypothyroidism	0.024	0.034	CbGeAlD
Ingenol Mebutate—PRKCD—blood—hypothyroidism	0.024	0.034	CbGeAlD
Ingenol Mebutate—PRKCD—thyroid gland—hypothyroidism	0.0231	0.0329	CbGeAlD
Ingenol Mebutate—PRKCD—female gonad—hypothyroidism	0.0224	0.0317	CbGeAlD
Ingenol Mebutate—PRKCD—testis—hypothyroidism	0.0198	0.0282	CbGeAlD
Ingenol Mebutate—PRKCA—Regulation of KIT signaling—SH2B3—hypothyroidism	0.0188	0.0635	CbGpPWpGaD
Ingenol Mebutate—PRKCD—liver—hypothyroidism	0.0187	0.0266	CbGeAlD
Ingenol Mebutate—PRKCD—cerebellum—hypothyroidism	0.0183	0.026	CbGeAlD
Ingenol Mebutate—PRKCA—heart—hypothyroidism	0.0177	0.0251	CbGeAlD
Ingenol Mebutate—PRKCA—cardiovascular system—hypothyroidism	0.0167	0.0237	CbGeAlD
Ingenol Mebutate—PRKCA—gonad—hypothyroidism	0.0152	0.0215	CbGeAlD
Ingenol Mebutate—PRKCA—pituitary gland—hypothyroidism	0.0148	0.021	CbGeAlD
Ingenol Mebutate—PRKCA—adrenal gland—hypothyroidism	0.0132	0.0188	CbGeAlD
Ingenol Mebutate—PRKCA—blood—hypothyroidism	0.0132	0.0188	CbGeAlD
Ingenol Mebutate—PRKCA—thyroid gland—hypothyroidism	0.0128	0.0181	CbGeAlD
Ingenol Mebutate—PRKCA—female gonad—hypothyroidism	0.0123	0.0175	CbGeAlD
Ingenol Mebutate—PRKCA—testis—hypothyroidism	0.0109	0.0155	CbGeAlD
Ingenol Mebutate—PRKCA—liver—hypothyroidism	0.0103	0.0147	CbGeAlD
Ingenol Mebutate—PRKCA—cerebellum—hypothyroidism	0.0101	0.0143	CbGeAlD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—PIK3C2A—hypothyroidism	0.00884	0.0299	CbGpPWpGaD
Ingenol Mebutate—PRKCD—IGF1 pathway—IGF1—hypothyroidism	0.00835	0.0282	CbGpPWpGaD
Ingenol Mebutate—PRKCD—TCR Signaling Pathway—SH2B3—hypothyroidism	0.00821	0.0277	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PCP/CE pathway—CLTC—hypothyroidism	0.00687	0.0232	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Fcgamma receptor (FCGR) dependent phagocytosis—VAV3—hypothyroidism	0.00613	0.0207	CbGpPWpGaD
Ingenol Mebutate—PRKCD—G alpha (q) signalling events—TRH—hypothyroidism	0.00576	0.0195	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Ceramide signaling pathway—IGF1—hypothyroidism	0.00574	0.0194	CbGpPWpGaD
Ingenol Mebutate—PRKCD—TCR Signaling Pathway—VAV3—hypothyroidism	0.00563	0.019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00523	0.0177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—PIK3C2A—hypothyroidism	0.00518	0.0175	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00515	0.0174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—PIK3C2A—hypothyroidism	0.00508	0.0172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.0049	0.0166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—beta-catenin independent WNT signaling—CLTC—hypothyroidism	0.00474	0.016	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—VAV3—hypothyroidism	0.00463	0.0157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00448	0.0152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—ZNF764—hypothyroidism	0.0043	0.0145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—SLC5A7—hypothyroidism	0.00401	0.0135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Opioid Signalling—POMC—hypothyroidism	0.00392	0.0133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—VAV3—hypothyroidism	0.00387	0.0131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Corticotropin-releasing hormone—POMC—hypothyroidism	0.00354	0.012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.00352	0.0119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—VAV3—hypothyroidism	0.00349	0.0118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00337	0.0114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.00329	0.0111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—VAV3—hypothyroidism	0.00328	0.0111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—G alpha (q) signalling events—AVP—hypothyroidism	0.00302	0.0102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—PIK3C2A—hypothyroidism	0.00297	0.0101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00296	0.00999	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.00295	0.00999	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.00282	0.00952	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—THRA—hypothyroidism	0.00277	0.00937	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.00275	0.00928	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.0027	0.00914	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—VAV3—hypothyroidism	0.00266	0.00899	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—NEFL—hypothyroidism	0.00258	0.00873	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—CLTC—hypothyroidism	0.00251	0.00848	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ZNF764—hypothyroidism	0.00247	0.00835	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.00246	0.0083	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Opioid Signalling—POMC—hypothyroidism	0.00225	0.00762	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—VAV3—hypothyroidism	0.00223	0.00755	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.00209	0.00705	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SH2B3—hypothyroidism	0.00206	0.00697	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—POMC—hypothyroidism	0.00204	0.00688	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.00202	0.00683	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—VAV3—hypothyroidism	0.002	0.00677	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NKX2-5—hypothyroidism	0.00197	0.00668	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—VAV3—hypothyroidism	0.00188	0.00637	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—THRB—hypothyroidism	0.00179	0.00604	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.00169	0.00572	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—TRH—hypothyroidism	0.00164	0.00554	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—THRA—hypothyroidism	0.00159	0.00538	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.00158	0.00533	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CLTC—hypothyroidism	0.00157	0.00532	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00155	0.00525	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—TRH—hypothyroidism	0.00149	0.00504	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—TSHB—hypothyroidism	0.00146	0.00494	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—TSHR—hypothyroidism	0.00146	0.00494	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—IYD—hypothyroidism	0.00146	0.00492	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—VAV3—hypothyroidism	0.00142	0.00478	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—TSHB—hypothyroidism	0.00133	0.00449	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—TSHR—hypothyroidism	0.00133	0.00449	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—VAV3—hypothyroidism	0.00128	0.00434	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—VAV3—hypothyroidism	0.00127	0.00431	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ATP5O—hypothyroidism	0.00124	0.00418	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SH2B3—hypothyroidism	0.00118	0.004	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TPO—hypothyroidism	0.00116	0.00393	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NKX2-5—hypothyroidism	0.00113	0.00383	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00109	0.00369	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—THRB—hypothyroidism	0.00103	0.00347	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CLTC—hypothyroidism	0.00102	0.00344	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000971	0.00328	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TRH—hypothyroidism	0.000942	0.00318	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CLTC—hypothyroidism	0.000904	0.00306	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—VAV3—hypothyroidism	0.000894	0.00302	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TRH—hypothyroidism	0.00088	0.00297	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IGF1—hypothyroidism	0.000871	0.00295	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AVP—hypothyroidism	0.000862	0.00291	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TRH—hypothyroidism	0.000855	0.00289	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TSHB—hypothyroidism	0.00084	0.00284	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TSHR—hypothyroidism	0.00084	0.00284	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VAV3—hypothyroidism	0.000813	0.00275	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—VAV3—hypothyroidism	0.000812	0.00275	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PRL—hypothyroidism	0.000802	0.00271	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TSHR—hypothyroidism	0.000784	0.00265	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TSHB—hypothyroidism	0.000784	0.00265	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AVP—hypothyroidism	0.000782	0.00265	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TSHB—hypothyroidism	0.000762	0.00258	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TSHR—hypothyroidism	0.000762	0.00258	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—VAV3—hypothyroidism	0.000742	0.00251	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PRL—hypothyroidism	0.000741	0.0025	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—VAV3—hypothyroidism	0.000732	0.00247	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SH2B3—hypothyroidism	0.000699	0.00236	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CLTC—hypothyroidism	0.000585	0.00198	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—POMC—hypothyroidism	0.000573	0.00194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TSHB—hypothyroidism	0.000539	0.00182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—POMC—hypothyroidism	0.00052	0.00176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PRL—hypothyroidism	0.000519	0.00175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—VAV3—hypothyroidism	0.000514	0.00174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TRH—hypothyroidism	0.000505	0.00171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IGF1—hypothyroidism	0.000501	0.00169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AVP—hypothyroidism	0.000495	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3C2A—hypothyroidism	0.00048	0.00162	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VAV3—hypothyroidism	0.00048	0.00162	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—VAV3—hypothyroidism	0.000466	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AVP—hypothyroidism	0.000462	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PRL—hypothyroidism	0.000461	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TSHB—hypothyroidism	0.00045	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TSHR—hypothyroidism	0.00045	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AVP—hypothyroidism	0.000449	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—VAV3—hypothyroidism	0.000426	0.00144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PRL—hypothyroidism	0.000425	0.00144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC5A5—hypothyroidism	0.000403	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SH2B3—hypothyroidism	0.000401	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—POMC—hypothyroidism	0.000329	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—POMC—hypothyroidism	0.000307	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—POMC—hypothyroidism	0.000299	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRL—hypothyroidism	0.000298	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1—hypothyroidism	0.000295	0.000999	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VAV3—hypothyroidism	0.000276	0.000932	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AVP—hypothyroidism	0.000265	0.000897	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—POMC—hypothyroidism	0.000211	0.000713	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—POMC—hypothyroidism	0.000176	0.000596	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1—hypothyroidism	0.00017	0.000574	CbGpPWpGaD
